Girgis, I., Chimalakonda, A., Jones III, J., Dockens, R., Marchisin, D., Darbenzio, R., Singhal, S., Throup, J. and Banerjee, S. 2019. Lack of ECG effects of BMS-986165, an oral, selective tyrosine kinase 2 (TYK2) inhibitor: results from a thorough QT study in healthy subjects. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S13. DOI:https://doi.org/10.25251/skin.3.supp.13.